Is it time to revisit follicle-stimulating hormone therapy in men with azoospermia?

Richard J. Fantus; Joshua A. Halpern; Robert E. Brannigan

doi:10.1016/j.fertnstert.2020.12.035

Is it time to revisit follicle-stimulating hormone therapy in men with azoospermia?

Richard J. Fantus, Joshua A. Halpern, Robert E. Brannigan

Urology

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	576-577
Number of pages	2
Journal	Fertility and Sterility
Volume	115
Issue number	3
DOIs	https://doi.org/10.1016/j.fertnstert.2020.12.035
State	Published - Mar 2021

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.fertnstert.2020.12.035

Cite this

@article{c2a93b90816249a88d519af53296afd2,

title = "Is it time to revisit follicle-stimulating hormone therapy in men with azoospermia?",

author = "Fantus, {Richard J.} and Halpern, {Joshua A.} and Brannigan, {Robert E.}",

year = "2021",

month = mar,

doi = "10.1016/j.fertnstert.2020.12.035",

language = "English (US)",

volume = "115",

pages = "576--577",

journal = "Fertility and Sterility",

issn = "0015-0282",